Curative Biosciences Stock Buy Hold or Sell Recommendation
| CBDX Stock | USD 0.0001 0.00 0.00% |
Given the investment horizon of 90 days and complete risk avoidance on your part, our recommendation regarding Curative Biosciences is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Curative Biosciences given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Curative Biosciences, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Curative Biosciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Curative and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Curative Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
Curative |
Execute Curative Biosciences Buy or Sell Advice
The Curative recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Curative Biosciences. Macroaxis does not own or have any residual interests in Curative Biosciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Curative Biosciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Curative Biosciences Trading Alerts and Improvement Suggestions
| Curative Biosciences generated a negative expected return over the last 90 days | |
| Curative Biosciences has some characteristics of a very speculative penny stock | |
| Curative Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (53.2 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Curative Biosciences currently holds about 982 in cash with (12.8 K) of positive cash flow from operations. | |
| Roughly 76.0% of the company shares are held by company insiders |
Curative Biosciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Curative Biosciences or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Curative Biosciences' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Curative pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Curative Biosciences Volatility Alert
At this time Curative Biosciences exhibits very low volatility. Curative Biosciences appears to be a penny stock. Although Curative Biosciences may be, in fact, a solid short-term or long term investment, many penny pink sheets are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in Curative Biosciences or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Curative instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Curative Biosciences Fundamentals Vs Peers
Comparing Curative Biosciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Curative Biosciences' direct or indirect competition across all of the common fundamentals between Curative Biosciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Curative Biosciences or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Curative Biosciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Curative Biosciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Curative Biosciences to competition |
| Fundamentals | Curative Biosciences | Peer Average |
| Return On Asset | -38.44 | -0.14 |
| Current Valuation | 9.68 M | 16.62 B |
| Shares Outstanding | 31.57 M | 571.82 M |
| Shares Owned By Insiders | 76.24 % | 10.09 % |
| EBITDA | (50.35 K) | 3.9 B |
| Net Income | (53.2 K) | 570.98 M |
| Cash And Equivalents | 982 | 2.7 B |
| Total Debt | 156.45 K | 5.32 B |
| Book Value Per Share | (0.04) X | 1.93 K |
| Cash Flow From Operations | (12.8 K) | 971.22 M |
| Earnings Per Share | (0.03) X | 3.12 X |
| Number Of Employees | 5 | 18.84 K |
| Beta | 8.19 | -0.15 |
| Market Capitalization | 10.56 M | 19.03 B |
| Total Asset | 2.27 K | 29.47 B |
| Z Score | -32.4 | 8.72 |
| Net Asset | 2.27 K |
Curative Biosciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Curative . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
About Curative Biosciences Buy or Sell Advice
When is the right time to buy or sell Curative Biosciences? Buying financial instruments such as Curative Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Curative Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Macroaxis Index Thematic Idea Now
Macroaxis Index
An experimental equal-weighted index theme of selected equities generated based on Macroaxis rating and scoring system. The Macroaxis Index theme has 52 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Macroaxis Index Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Curative Pink Sheet Analysis
When running Curative Biosciences' price analysis, check to measure Curative Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curative Biosciences is operating at the current time. Most of Curative Biosciences' value examination focuses on studying past and present price action to predict the probability of Curative Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curative Biosciences' price. Additionally, you may evaluate how the addition of Curative Biosciences to your portfolios can decrease your overall portfolio volatility.